EP2398486A4 - Compositions and methods to prevent and/or treat cancer with pa -card - Google Patents

Compositions and methods to prevent and/or treat cancer with pa -card

Info

Publication number: EP2398486A4
Authority: EP; European Patent Office
Prior art keywords: card; compositions; methods; prevent; treat cancer
Prior art date: 2009-02-20
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP10744428A

Other languages

German (de)

French (fr)

Other versions

EP2398486A1 (en

Inventor

Gupta Tapas Das

Ananda Chakrabarty

Arsenio Fialho

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

CDG Therapeutics Inc

Original Assignee

CDG Therapeutics Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-02-20

Filing date

2010-02-22

Publication date

2012-11-21

2010-02-22 Application filed by CDG Therapeutics Inc filed Critical CDG Therapeutics Inc

2011-12-28 Publication of EP2398486A1 publication Critical patent/EP2398486A1/en

2012-11-21 Publication of EP2398486A4 publication Critical patent/EP2398486A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
- A61K38/4873—Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Immunology (AREA)
Zoology (AREA)
Hematology (AREA)
Oncology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

EP10744428A 2009-02-20 2010-02-22 Compositions and methods to prevent and/or treat cancer with pa -card Withdrawn EP2398486A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US15423609P	2009-02-20	2009-02-20
US17943509P	2009-05-19	2009-05-19
PCT/US2010/024904 WO2010096754A1 (en)	2009-02-20	2010-02-22	Compositions and methods to prevent and/or treat cancer with pa -card

Publications (2)

Publication Number	Publication Date
EP2398486A1 EP2398486A1 (en)	2011-12-28
EP2398486A4 true EP2398486A4 (en)	2012-11-21

Family

ID=42634238

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP10744428A Withdrawn EP2398486A4 (en)	2009-02-20	2010-02-22	Compositions and methods to prevent and/or treat cancer with pa -card

Country Status (9)

Country	Link
EP (1)	EP2398486A4 (en)
JP (1)	JP2012518417A (en)
KR (1)	KR20120000062A (en)
CN (1)	CN102387809A (en)
AU (1)	AU2010215858A1 (en)
CA (1)	CA2753121A1 (en)
IL (1)	IL214757A0 (en)
SG (1)	SG174136A1 (en)
WO (1)	WO2010096754A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2913805A1 (en)	2005-11-07	2007-05-18	Indiana University Research And Technology Corporation	Glucagon analogs exhibiting physiological solubility and stability
WO2014049604A2 (en) *	2012-09-05	2014-04-03	Amrita Therapeutics Limited	A novel biomedical device for cancer therapy
KR101773486B1 (en) *	2013-02-05	2017-08-31	애그리컬쳐럴 테크놀로지 리서치 인스티튜트	Anti-Mycoplasma Spp. Subunit Vaccine
CN103554187B (en) *	2013-09-18	2016-03-30	中国科学技术大学	Platinum complexes, protein complex of being obtained by this platinum compound and preparation method thereof
USD844857S1 (en) *	2017-10-05	2019-04-02	Western Interlock, Inc.	Retaining wall corner block

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020164703A1 (en) *	2000-12-21	2002-11-07	Krzysztof Pawlowski	Card-domain containing polypeptides, encoding nucleic acids, and methods of use
WO2003097085A1 (en) *	2002-05-16	2003-11-27	University College London	Ddah modulators in the treatment of pain

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2336416T3 (en) *	1999-01-26	2010-04-13	University College London	DIMETHYLARGININE DIMETHYLAMINE HYDROLASE.
UA97466C2 (en) *	2004-10-07	2012-02-27	Ананда Чакрабарти	Cupredoxin derived transport agents and methods of use thereof

2010
- 2010-02-22 KR KR1020117021883A patent/KR20120000062A/en not_active Application Discontinuation
- 2010-02-22 AU AU2010215858A patent/AU2010215858A1/en not_active Abandoned
- 2010-02-22 CA CA2753121A patent/CA2753121A1/en not_active Abandoned
- 2010-02-22 JP JP2011551270A patent/JP2012518417A/en active Pending
- 2010-02-22 WO PCT/US2010/024904 patent/WO2010096754A1/en active Application Filing
- 2010-02-22 EP EP10744428A patent/EP2398486A4/en not_active Withdrawn
- 2010-02-22 SG SG2011059458A patent/SG174136A1/en unknown
- 2010-02-22 CN CN2010800160848A patent/CN102387809A/en active Pending
2011
- 2011-08-18 IL IL214757A patent/IL214757A0/en unknown

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20020164703A1 (en) *	2000-12-21	2002-11-07	Krzysztof Pawlowski	Card-domain containing polypeptides, encoding nucleic acids, and methods of use
WO2003097085A1 (en) *	2002-05-16	2003-11-27	University College London	Ddah modulators in the treatment of pain

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
NI ET AL: "Arginine deiminase, a potential anti-tumor drug", CANCER LETTERS, NEW YORK, NY, US, vol. 261, no. 1, 7 January 2008 (2008-01-07), pages 1 - 11, XP022458995, ISSN: 0304-3835 *
See also references of WO2010096754A1 *

Also Published As

Publication number	Publication date
CN102387809A (en)	2012-03-21
AU2010215858A1 (en)	2011-09-22
KR20120000062A (en)	2012-01-03
CA2753121A1 (en)	2010-08-26
EP2398486A1 (en)	2011-12-28
WO2010096754A8 (en)	2011-04-28
JP2012518417A (en)	2012-08-16
SG174136A1 (en)	2011-10-28
WO2010096754A1 (en)	2010-08-26
IL214757A0 (en)	2011-11-30

Publication	Publication Date	Title
IL218987A0 (en)	2012-06-28	Methods and compositions for treating cancer
EP2419137A4 (en)	2013-01-09	Compositions and methods to treat acute myelogenous leukemia
IL239918A0 (en)	2015-08-31	Compositions and methods for treating colitis
ZA201207574B (en)	2014-09-25	Phytocannabinoids in the treatment of cancer
IL215932A0 (en)	2011-12-29	Compositions and methods for treating burns
IL218212A0 (en)	2012-04-30	Therapeutic methods and compositions
HK1159498A1 (en)	2012-08-03	Methods and compositions for the treatment of cancer
ZA200905508B (en)	2010-07-28	Compositions and methods to prevent cancer with cupredoxins
SG10201500124VA (en)	2015-03-30	Methods and Compositions for Treating Cancer
EP2429584A4 (en)	2013-02-20	Methods and compositions for treatment
GB0903299D0 (en)	2009-04-08	Composition and methods
EP2340027A4 (en)	2012-04-04	Methods and compositions for the treatment of cancer
IL214500A0 (en)	2011-09-27	Compositions and methods for extended therapy with aminopyridines
IL214349A0 (en)	2011-09-27	Compositions and methods for the treatment of cancer
IL214757A0 (en)	2011-11-30	Compositions and methods to prevent and/or treat cancer with pa-card
IL213636A0 (en)	2011-07-31	Compositions and methods to prevent cancer with cupredoxins
GB0901494D0 (en)	2009-03-11	Compositions and Methods
IL213657A0 (en)	2011-07-31	Compositions and methods to prevent cancer with cupredoxins
EP2411031A4 (en)	2012-08-01	Methods and compositions for the treatment of cancer
EP2461870A4 (en)	2013-04-17	Therapeutic compositions and methods
IL213919A0 (en)	2011-07-31	Methods to treat cancer
EP2582384A4 (en)	2014-03-12	Compositions and methods for treating cancer
EP2537031A4 (en)	2013-07-17	Compositions and methods for treating cancer
GB201718726D0 (en)	2017-12-27	Phytocannabinoids in the treatment of cancer
GB0909720D0 (en)	2009-07-22	Compositions and methods

Legal Events

Date	Code	Title	Description
2011-11-25	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2011-12-28	17P	Request for examination filed	Effective date: 20110920
2011-12-28	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO SE SI SK SM TR
2012-05-30	DAX	Request for extension of the european patent (deleted)
2012-11-21	A4	Supplementary search report drawn up and despatched	Effective date: 20121024
2012-11-21	RIC1	Information provided on ipc code assigned before grant	Ipc: A61K 38/48 20060101AFI20121019BHEP Ipc: A61P 35/00 20060101ALI20121019BHEP
2013-10-18	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2013-11-20	18D	Application deemed to be withdrawn	Effective date: 20130523